Cargando…

An Update in Epigenetics in Metabolic-Associated Fatty Liver Disease

Metabolic-associated fatty liver disease (MAFLD) is characterized by hepatic steatosis accompanied by one of three features: overweight or obesity, T2DM, or lean or normal weight with evidence of metabolic dysregulation. It is distinguished by excessive fat accumulation in hepatocytes, and a decreas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodríguez-Sanabria, J. Samael, Escutia-Gutiérrez, Rebeca, Rosas-Campos, Rebeca, Armendáriz-Borunda, Juan S., Sandoval-Rodríguez, Ana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787199/ https://www.ncbi.nlm.nih.gov/pubmed/35087844 http://dx.doi.org/10.3389/fmed.2021.770504

Ejemplares similares

Pirfenidone modifies hepatic miRNAs expression in a model of MAFLD/NASH
por: Escutia-Gutiérrez, Rebeca, et al.
Publicado: (2021)

Mexican Ancestral Foods (Theobroma cacao, Opuntia ficus indica, Persea americana and Phaseolus vulgaris) Supplementation on Anthropometric, Lipid and Glycemic Control Variables in Obese Patients: A Systematic Review and Meta-Analysis
por: Escutia-Gutiérrez, Rebeca, et al.
Publicado: (2023)

Moringa oleifera Improves MAFLD by Inducing Epigenetic Modifications
por: Monraz-Méndez, C. Alejandra, et al.
Publicado: (2022)

Advances of Nanotechnology in the Diagnosis and Treatment of Hepatocellular Carcinoma
por: Escutia-Gutiérrez, Rebeca, et al.
Publicado: (2023)

Dietary supplementation with Mexican foods, Opuntia ficus indica, Theobroma cacao, and Acheta domesticus: Improving obesogenic and microbiota features in obese mice
por: Rosas-Campos, Rebeca, et al.
Publicado: (2022)

Editorial: Liver Fibrosis and MAFLD: From Molecular Aspects to Novel Pharmacological Strategies
por: Sandoval-Rodriguez, Ana, et al.
Publicado: (2022)

Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice
por: Rodriguez-Echevarria, Roberto, et al.
Publicado: (2018)

PPARs as Metabolic Sensors and Therapeutic Targets in Liver Diseases
por: Monroy-Ramirez, Hugo Christian, et al.
Publicado: (2021)

Epidemiologic, Genetic, Pathogenic, Metabolic, Epigenetic Aspects Involved in NASH-HCC: Current Therapeutic Strategies
por: Gutiérrez-Cuevas, Jorge, et al.
Publicado: (2022)

Roles of Nrf2 in Liver Diseases: Molecular, Pharmacological, and Epigenetic Aspects
por: Galicia-Moreno, Marina, et al.
Publicado: (2020)

Update on genetics and epigenetics in metabolic associated fatty liver disease
por: Zhu, Xiaopeng, et al.
Publicado: (2022)

The multifaceted role of pirfenidone and its novel targets
por: Macías-Barragán, José, et al.
Publicado: (2010)

Simultaneous Administration of ADSCs-Based Therapy and Gene Therapy Using Ad-huPA Reduces Experimental Liver Fibrosis
por: Meza-Ríos, Alejandra, et al.
Publicado: (2016)

Molecular Basis and Current Treatment for Alcoholic Liver Disease
por: Miranda-Mendez, Alejandra, et al.
Publicado: (2010)

Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease
por: Perdomo, Carolina M., et al.
Publicado: (2022)

Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review
por: Delli Bovi, Anna Pia, et al.
Publicado: (2021)

Pathophysiological Molecular Mechanisms of Obesity: A Link between MAFLD and NASH with Cardiovascular Diseases
por: Gutiérrez-Cuevas, Jorge, et al.
Publicado: (2021)

Role of Carnitine in Non-alcoholic Fatty Liver Disease and Other Related Diseases: An Update
por: Li, Na, et al.
Publicado: (2021)

Delphinidin Ameliorates Hepatic Triglyceride Accumulation in Human HepG2 Cells, but Not in Diet-Induced Obese Mice
por: Parra-Vargas, Marcela, et al.
Publicado: (2018)

The Role of NRF2 in Obesity-Associated Cardiovascular Risk Factors
por: Gutiérrez-Cuevas, Jorge, et al.
Publicado: (2022)

Hypoxia and Non-alcoholic Fatty Liver Disease
por: Isaza, Stephania C., et al.
Publicado: (2020)

Protective Effects of Moringa oleifera on HBV Genotypes C and H Transiently Transfected Huh7 Cells
por: Feustel, Sina, et al.
Publicado: (2017)

Update cognition of nonalcoholic fatty liver disease/metabolism‐associated fatty liver disease
por: Gu, Weijun, et al.
Publicado: (2022)

Molecular Mechanisms of Obesity-Linked Cardiac Dysfunction: An Up-Date on Current Knowledge
por: Gutiérrez-Cuevas, Jorge, et al.
Publicado: (2021)

Psychological Biomarkers and Fibrosis: An Innovative Approach to Non-alcoholic Fatty Liver Disease
por: Funuyet-Salas, Jesús, et al.
Publicado: (2020)

Correction: Human adipose derived stem cells regress fibrosis in a chronic renal fibrotic model induced by adenine
por: Rivera-Valdés, Juan José, et al.
Publicado: (2018)

Human adipose derived stem cells regress fibrosis in a chronic renal fibrotic model induced by adenine
por: Rivera-Valdés, Juan José, et al.
Publicado: (2017)

Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update
por: Alharthi, Jawaher, et al.
Publicado: (2022)

Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease
por: Kazankov, Konstantin, et al.
Publicado: (2020)

Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
por: Idalsoaga, Francisco, et al.
Publicado: (2020)

Oral Manifestations of COVID-19: Updated Systematic Review With Meta-Analysis
por: Aragoneses, Javier, et al.
Publicado: (2021)

Appendicular Skeletal Muscle Index and HbA1c Evaluate Liver Steatosis in Patients With Metabolic Associated Fatty Liver Disease
por: Jin, Rui, et al.
Publicado: (2022)

Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update
por: Fouda, Sherouk, et al.
Publicado: (2022)

Endoscopic Bariatric and Metabolic Therapies and Their Effects on Metabolic Syndrome and Non-alcoholic Fatty Liver Disease - A Systematic Review and Meta-Analysis
por: Lee, Shi-Yan, et al.
Publicado: (2022)

Hydrodynamics-based liver transfection achieves gene silencing of CB1 using short hairpin RNA plasmid in cirrhotic rats
por: Díaz-Rivera, Adriana, et al.
Publicado: (2020)

Non-alcoholic/Metabolic-Associated Fatty Liver Disease and Helicobacter pylori Additively Increase the Risk of Arterial Stiffness
por: Choi, Ji Min, et al.
Publicado: (2022)

Unveiling the Role of the Fatty Acid Binding Protein 4 in the Metabolic-Associated Fatty Liver Disease
por: Moreno-Vedia, Juan, et al.
Publicado: (2022)

Potential Effects of Coronaviruses on the Liver: An Update
por: Wang, Xinyi, et al.
Publicado: (2021)

An update on animal models of liver fibrosis
por: Wu, ShuTing, et al.
Publicado: (2023)

Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability
por: Campos-Valdez, Marina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ksn74e40oja3erugtqg6df15jj